|
|
|
|
| LEADER |
01289nam a2200253 u 4500 |
| 001 |
EB002010777 |
| 003 |
EBX01000000000000001173676 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
220201 r ||| eng |
| 100 |
1 |
|
|a Lachance, Chantelle
|
| 245 |
0 |
0 |
|a Magnetic resonance imaging-guided radiotherapy delivery systems for cancer treatment
|h Elektronische Ressource
|b a review of clinical effectiveness, cost-effectiveness and guidelines
|c Chantelle Lachance, Suzanne McCormack
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b CADTH
|c 2019, March 25, 2019
|
| 300 |
|
|
|a 1 PDF file (14 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 700 |
1 |
|
|a McCormack, Suzanne
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK546999
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The aim of this report is to summarize the evidence regarding the clinical and cost effectiveness, as well as guidelines for the use of MRgRT delivery systems for the treatment of patients with cancer requiring radiotherapy
|